The Accuracy of the Edmonton Symptom Assessment System for the Assessment of Depression in Patients With Cancer: A Systematic Review and Meta-Analysis
- 29 November 2017
- journal article
- research article
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
- Vol. 35 (4) , 731-739
Abstract
Background: Depression is a common health problem among patients with cancer. The Edmonton Symptom Assessment System (ESAS) is one of many tools that have been used to evaluate depression in these patients. Nevertheless, the diagnostic performance and the appropriate cutoff point of the ESAS for the assessment of depression in these patients have varied in the studies. Purpose: To determine the diagnostic accuracy and the optimal cutoff point for the ESAS for the assessment of depression in patients with cancer. Data Sources: PubMed, Scopus, CINAHL, and Cochrane library databases from inception to September 18, 2016. Study Selection: Paired reviewers independently screened abstracts and full-text articles for all cross-sectional studies published in English and compared these with the ESAS in the depression (ESAS-D) subscale with reference to standard tests for the assessment of depression. Data Extraction: Two reviewers serially abstracted the data and independently assessed the risk of bias by using the Quality Assessment of Diagnostic Accuracy Studies 2. Data Synthesis: A total of 6 studies were eligible for review. Our meta-analysis showed the optimal cutoff point of the ESAS-D ≥ 4, with pooled sensitivity and specificity at 53% (95% confidence interval [CI]: 38%-67%) and 90% (95% CI: 82%-94%), respectively. The positive likelihood ratio and diagnostic odds ratio of the ESAS-D ≥ 4 were 5.2 (95% CI: 3.1-8.6) and 10 (95% CI: 5-19). There was a high degree of heterogeneity between the studies ( P value <.001, I 2 = 96%). Conclusion: We suggest that an ESAS-D ≥ 4 could be used to detect possible cases of depression in patients with cancer. Registration: Our study protocol was registered with the International Prospective Register of Systematic Reviews on October 4, 2016, and was last updated on January 11, 2017 (registration number CRD42016048288).Keywords
This publication has 20 references indexed in Scilit:
- Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010PLOS Medicine, 2013
- The utility of the Edmonton Symptom Assessment System in screening for anxiety and depressionEuropean Journal of Cancer Care, 2012
- Psychosocial health care needs assessment of adult cancer patients: a consensus-based guidelineSupportive Care in Cancer, 2012
- Frequency of depression among oncology outpatients and association with other symptomsSupportive Care in Cancer, 2012
- Reliability and Validity of a Thai Version of the Edmonton Symptom Assessment Scale (ESAS-Thai)Journal of Pain and Symptom Management, 2011
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Gender differences in prevalence of depression among patients receiving palliative care: The role of dependencyPalliative Medicine, 2011
- The development of evidence-based European guidelines on the management of depression in palliative cancer careEuropean Journal of Cancer, 2011
- Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studiesThe Lancet Oncology, 2011
- The Edmonton Symptom Assessment System as a Screening Tool for Depression and AnxietyJournal of Palliative Medicine, 2006